RDY Stock | | | USD 70.92 0.57 0.80% |
This module uses fundamental data of Dr Reddys to approximate its Piotroski F score. Dr Reddys F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Dr Reddys Laboratories. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Dr Reddys financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Dr Reddys Altman Z Score,
Dr Reddys Correlation,
Dr Reddys Valuation, as well as analyze
Dr Reddys Alpha and Beta and
Dr Reddys Hype Analysis.
At this time, Dr Reddys'
Short Term Debt is fairly stable compared to the past year.
Short and Long Term Debt is likely to rise to about 17.2
B in 2024, whereas
Long Term Debt is likely to drop 0.00 in 2024. At this time, Dr Reddys'
Net Income Per Share is fairly stable compared to the past year.
Days Of Inventory On Hand is likely to rise to 391.25 in 2024, whereas
Price To Sales Ratio is likely to drop 3.48 in 2024.
At this time, it appears that Dr Reddys' Piotroski F Score is Healthy. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
5.0
Piotroski F Score - Healthy
| Current Return On Assets | Positive | Focus |
| Change in Return on Assets | Decreased | Focus |
| Cash Flow Return on Assets | Positive | Focus |
| Current Quality of Earnings (accrual) | Improving | Focus |
| Asset Turnover Growth | Decrease | Focus |
| Current Ratio Change | Decrease | Focus |
| Long Term Debt Over Assets Change | Lower Leverage | Focus |
| Change In Outstending Shares | Decrease | Focus |
| Change in Gross Margin | No Change | Focus |
Dr Reddys Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Dr Reddys is to make sure RDY is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Dr Reddys' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Dr Reddys' financial numbers are properly reported.
Dr Reddys Laboratories F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Dr Reddys' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Dr Reddys in a much-optimized way.
Click cells to compare fundamentals
About Dr Reddys Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Dr Reddys Current Valuation Drivers
We derive many important indicators used in calculating different scores of Dr Reddys from analyzing Dr Reddys' financial statements. These drivers represent accounts that assess Dr Reddys' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Dr Reddys' important valuation drivers and their relationship over time.
| | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) |
Market Cap | | 511.9B | 746.6B | 702.3B | 776.0B | 698.4B | 733.4B |
Enterprise Value | | 531.9B | 762.0B | 721.2B | 783.7B | 705.4B | 740.6B |
About Dr Reddys Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dr Reddys Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Reddys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Dr Reddys Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Dr Reddys Laboratories
offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys'
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock: Complementary Tools for RDY Stock analysis
When running Dr Reddys' price analysis, check to
measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to
predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost
the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth | Dividend Share | Earnings Share | Revenue Per Share | Quarterly Revenue Growth |
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine
if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.